Search

The integration of artificial intelligence (AI) into healthcare systems marked a pivotal evolution in clinical analytics architectures and governance structures, transforming data-driven decision-making from siloed, retrospective analyses to dynamic, predictive, and integrated frameworks. This period witnessed rapid advancements in machine learning (ML) applications for healthcare infrastructure, encompassing electronic health records (EHRs), imaging diagnostics, population health management, and real-time monitoring systems. Key developments included the shift toward federated learning to address data privacy concerns, the emergence of explainable AI (XAI) to enhance clinical trustworthiness, and the standardization of regulatory pathways for AI as medical devices. Architecturally, healthcare systems evolved from static analytics pipelines—where data ingestion, model training, and inference occurred in isolated phases—to adaptive, closed-loop configurations that incorporate feedback mechanisms for continuous model refinement and human-AI collaboration. Governance structures are adapted accordingly, emphasizing ethical frameworks to mitigate bias, ensure data equity, and promote algorithmic accountability, particularly for underserved populations. This review synthesizes literature from this timeframe, highlighting how AI-enabled analytics architectures facilitated precision medicine by integrating multimodal data sources, such as genomics, wearables, and social determinants of health, into cohesive systems. Challenges in interoperability and scalability were addressed through consensus guidelines like CONSORT-AI and SPIRIT-AI, which promoted transparent reporting of AI interventions in clinical trials. Moreover, the COVID-19 pandemic accelerated AI deployment in pandemic response systems, underscoring the need for resilient architectures capable of handling real-time data surges and uncertainty communication. Governance evolved to include multi-stakeholder perspectives, from regulatory bodies such as the FDA to clinical practitioners, ensuring that AI tools align with evidence-based medicine. This narrative review provides an original systems-level framing, organizing the literature around data-to-decision cycles, infrastructural integration, and governance maturation. By examining cross-study insights, it reveals how AI has fostered intelligent healthcare ecosystems, reducing diagnostic bias across diverse cohorts and enhancing decision support without over-relying on black-box models. Ultimately, this synthesis underscores the transition from AI as a supplementary tool to a foundational element of healthcare systems, paving the way for equitable, efficient clinical analytics.

The integration of artificial intelligence (AI) into healthcare systems and analytics has revolutionized clinical workflows, enabling predictive analytics, diagnostic support, and personalized interventions. However, this embedding raises profound ethical, liability, and regulatory challenges that must be addressed to ensure safe, equitable, and effective deployment. This narrative review synthesizes literature governance frameworks for AI-embedded healthcare, focusing on systems-level infrastructure and clinical analytics.Ethically, AI systems introduce risks of bias amplification, where algorithms trained on non-representative datasets perpetuate disparities in health outcomes, as seen in racial biases in risk prediction tools. Privacy concerns escalate as data mining from digital phenotyping proliferates, necessitating robust consent mechanisms and transparency in algorithmic decision-making. Liability allocation remains ambiguous, particularly for physicians using AI tools, where harms from opaque “black-box” models complicate accountability among developers, clinicians, and institutions. Regulatory governance demands a shift from product-centric to system-view approaches, incorporating human-AI interactions, ongoing monitoring, and adaptive oversight, as proposed for AI/ML-based software as medical devices (SaMD).In healthcare systems, AI analytics facilitate end-to-end loops from data ingestion to intervention feedback, but require governance to mitigate distributional shifts and automation complacency. Clinical decision support systems (CDSS) exemplify this, where AI augments human judgment but risks reinforcing outdated practices without ethical recalibration. Radiology is a key domain, and AI in imaging analytics underscores the need for multisociety ethical statements and regulatory vetting.This review provides an original synthesis that structures AI governance across data ecosystems, model transparency, deployment integrity, and feedback mechanisms. It underscores the imperative for interdisciplinary frameworks that prioritize patient well-being, fairness, and accountability, while avoiding over-speculation. By integrating cross-study insights, we position governance as integral to AI’s infrastructural role in healthcare, advocating for actionable ethics to bridge regulatory gaps and enhance the reliability of clinical analytics. Ultimately, effective governance will enable AI to converge with human expertise, fostering high-performance medicine without compromising equity or safety.

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.

The integration of artificial intelligence (AI) into healthcare systems has transformed population health analytics, enabling scalable infrastructures that process vast datasets to inform clinical decisions, resource allocation, and policy-making. This narrative review synthesizes recent literature on AI system architectures and governance models, focusing on how these elements underpin analytics-driven healthcare ecosystems. We examine the evolution of AI-enabled infrastructures, emphasizing federated learning, explainable models, and ethical frameworks to address data privacy, interoperability, and equity in population-level analytics. Key architectures include vertically integrated systems that streamline data ingestion, model deployment, and real-time inference, as seen in federated approaches that mitigate data silos while preserving patient confidentiality. Governance models are critical for ensuring trustworthy AI deployment, incorporating regulatory oversight, ethical principles adapted from military contexts to healthcare, and consensus-based guidelines for prediction models. We highlight the role of blockchain and data trusts in enhancing transparency and consent mechanisms, particularly in global health responses to pandemics and chronic disease management. The review structures the discourse around systems-level framing, integrating data flows, algorithmic decision support, and closed-loop feedback mechanisms that adapt to clinical outcomes. For instance, electronic health record (EHR)-based prediction models facilitate acute illness forecasting and outcome prediction in conditions like rheumatoid arthritis and oncology. We propose an original synthesis logic that conceptualizes AI infrastructures as adaptive networks, where governance acts as a regulatory layer overlaying architectural components to balance innovation with risk mitigation. Challenges such as bias in commercial datasets and the need for international cooperation are noted, but the emphasis remains on infrastructural resilience. Ultimately, this synthesis underscores the imperative for hybrid human-AI systems that prioritize population health equity, with governance models evolving to support sustainable analytics infrastructures. By positioning AI as a foundational tool for healthcare transformation, the review advocates for interdisciplinary collaboration to refine these systems, ensuring they deliver actionable insights while upholding ethical standards in diverse healthcare settings.

Generative artificial intelligence (GenAI) has emerged as a transformative force in healthcare systems, enabling advanced analytics, personalized interventions, and streamlined governance frameworks. This narrative review synthesizes recent literature on GenAI’s integration into healthcare infrastructures, emphasizing systems governance, safety protocols, and accountability mechanisms. We explore how GenAI enhances clinical decision-making, data analytics, and closed-loop systems while addressing ethical, regulatory, and operational challenges.At the core of healthcare systems, GenAI facilitates intelligent analytics by generating synthetic data for training models, simulating patient outcomes, and optimizing resource allocation. Governance frameworks are critical for ensuring responsible deployment, with studies highlighting the need for institutional guidelines that mitigate risks such as bias amplification and data privacy breaches. Safety considerations encompass algorithmic transparency, error detection in generative outputs, and human oversight in clinical loops. Accountability extends to lifecycle management, from model development to post-deployment monitoring, as evidenced by global initiatives and regional models like those in the GCC.The review delineates the landscape of GenAI applications in healthcare analytics, including predictive modeling for chronic disease management and real-time decision support. We propose an original systems-level framing that integrates data ingestion, inference generation, intervention deployment, and feedback recalibration under governance umbrellas. This synthesis reveals gaps in current infrastructures, such as the lack of standardized AI guardians for information overload and the challenges of scaling enterprise AI.In examining intelligent clinical decision systems, we highlight architectures that fuse GenAI with electronic health records (EHRs) for closed-loop operations, where generative models inform adaptive interventions. Ethical considerations are woven throughout, advocating for principles adapted from military contexts to healthcare. The adoption of GenAI in US hospitals underscores its potential for inpatient summaries and chronic care, yet calls for regulatory oversight to align with Helsinki declarations.Ultimately, this review positions GenAI as a cornerstone for accountable healthcare systems, urging interdisciplinary collaboration to balance innovation with safety. By synthesizing governance models, safety protocols, and accountability structures, we provide a roadmap for sustainable integration, fostering equitable health outcomes in an AI-augmented era.

The integration of artificial intelligence (AI) into healthcare systems marks a fundamental shift from isolated predictive analytics tools to embedded, scalable architectures that support autonomous governance. This narrative review synthesizes 28 peer-reviewed publications from leading journals to examine AI’s role across healthcare infrastructure and clinical analytics. Early work established deep learning foundations for risk prediction, diagnostic support, and prognostic modelling using multimodal data. These capabilities rapidly evolved into system-level applications that enhance data ingestion, real-time inference, and operational optimisation across entire care ecosystems.By the early 2020s, attention turned to deployment realities, including clinician acceptance, cost-effectiveness, and integration into existing workflows. Frameworks for responsible implementation emerged alongside regulatory perspectives that emphasise safety, equity, and continuous oversight. Recent contributions highlight the transition toward closed-loop systems in which predictive outputs inform decisions, trigger interventions, and feed outcome data back for model recalibration. Governance architectures now address ethical challenges, explainability gaps, and the move from generalist to specialised medical AI.This review organises the literature through an original systems-level lens spanning four interconnected pillars—data foundations, analytic intelligence, deployment mechanisms, and governance layers—rather than replicating prior application-specific taxonomies. Cross-study analysis reveals consistent patterns: predictive analytics serve as the foundational engine, clinical decision support acts as the execution layer, closed-loop feedback enables adaptation, and governance ensures sustainable autonomy. The synthesis demonstrates that AI is no longer an adjunct technology but a core infrastructural element reshaping how healthcare systems ingest, process, act upon, and learn from data at scale.Trajectory as a coherent progression toward autonomous yet human-centred governance, the review provides clinicians, system architects, and policymakers with a unified understanding of current capabilities and the infrastructural requirements for responsible scaling.

Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide, with prevalence expected to triple by 2050. Early detection is crucial for clinical trial enrollment and care planning, and multimodal data (MRI, PET, CSF biomarkers, and cognitive assessments) provides complementary information on neurodegeneration, metabolism, and protein aggregation. This systematic review synthesizes AI/ML approaches for early AD detection using multimodal data, focusing on fusion strategies and performance across disease stages. Following PRISMA guidelines, searches of PubMed, IEEE Xplore, Scopus, Web of Science, and arXiv (2017–2023) identified studies using ML/DL with at least two modalities and reporting diagnostic performance. From 1,247 records, 35 studies were included. MRI was the most used modality (>90%), followed by cognitive tests (70–80%), PET (40–50%), and CSF (20–30%). Early fusion was most common, with increasing use of intermediate fusion. Multimodal models achieved AUROC of 0.90–0.98 for AD vs controls, but lower performance (0.70–0.85) for predicting MCI conversion to AD. Overall, multimodal AI improves early AD detection, with strong performance for diagnosis but persistent challenges in forecasting MCI progression due to heterogeneity and limited longitudinal data.

The integration of artificial intelligence into clinical decision support systems offers improved diagnostic accuracy and efficiency, but the opacity of many machine learning models raises concerns about trust, accountability, and regulatory compliance. Explainable artificial intelligence (XAI) has been proposed to address this by making model predictions interpretable to clinicians; however, its true clinical value remains uncertain, and evaluation has not kept pace with methodological development. This systematic review aimed to identify XAI methods used in clinical decision support systems, assess how they are evaluated with clinicians, and determine whether explanations improve diagnostic accuracy, trust, mental models, and efficiency. Following PRISMA guidelines, we searched PubMed, Web of Science, IEEE Xplore, ACM Digital Library, and Scopus for studies published between 2017 and 2024. Eligible studies included original research evaluating XAI in clinical decision support systems with clinician participants and reporting quantitative or qualitative outcomes. Risk of bias was assessed using adapted QUADAS-2 and ROBIS tools, and findings were synthesized narratively with subgroup analyses. From 2,847 records, 68 studies were included. The most common XAI methods were SHAP-based feature attribution (38%), saliency or heatmap methods (29%), concept-based approaches such as TCAV (15%), and counterfactual or example-based explanations (12%). Radiology was the dominant field (54%), followed by dermatology (18%) and pathology (12%). Evaluation approaches were highly inconsistent, with few validated instruments and most studies relying on Likert-scale trust measures or qualitative feedback. Only 16% of studies showed improved diagnostic accuracy with explanations, 67% showed no significant effect, and 17% reported reduced accuracy due to over-reliance or misinterpretation. Although 82% of studies reported increased clinician trust, trust rarely correlated with actual diagnostic performance. Overall, while XAI methods are widely studied in clinical decision support, their evaluation is inconsistent and their benefits are limited. Explanations tend to increase clinician trust without reliably improving diagnostic accuracy, and may sometimes worsen performance, highlighting a trust–accuracy gap that poses important safety concerns for clinical deployment.

Synthetic electronic health record (EHR) data generation has emerged as a potential solution to balancing clinical data accessibility with patient privacy, using generative artificial intelligence to simulate tabular, longitudinal, and textual health records without exposing identifiable patient information. This critical review, informed by PRISMA-ScR methodology, examines studies published between 2017 and 2025 focusing on generative models for synthetic EHR creation, with particular attention to privacy risks, data fidelity, downstream task utility, and ethical or regulatory considerations. A total of 67 studies were included after systematic screening, showing a dominance of GAN-based approaches alongside growing use of diffusion models and large language models in recent years, although privacy assessment and benchmarking practices remain inconsistent. Overall, the evidence suggests that while synthetic EHR data can facilitate data sharing, research, and model development, achieving a balance between realism, utility, and privacy remains challenging, as high statistical fidelity does not necessarily translate into clinical usefulness and strong downstream performance does not ensure adequate privacy protection.

Sleep disorders, including obstructive sleep apnea, insomnia, restless legs syndrome, narcolepsy, and central sleep apnea, represent a major public health burden. Polysomnography is the diagnostic gold standard but is resource-intensive, leading to increasing use of home sleep apnea testing and wearable devices to improve accessibility. This systematic review evaluates deep learning models in sleep medicine across polysomnography, home sleep apnea testing, and wearable data, focusing on architectures, signal types, validation approaches, diagnostic tasks, and clinical readiness. A PRISMA 2020–compliant search was conducted in PubMed, IEEE Xplore, Scopus, and Web of Science for studies published from 2017 to 2025, including those applying deep learning for sleep staging, apnea/hypopnea detection, or sleep disorder diagnosis using PSG, HSAT, or wearable-derived signals. Twenty-nine studies were included. Convolutional neural networks were the most widely used architecture, often combined with recurrent or hybrid models for temporal dependencies, while transformer-based models have recently emerged for long-sequence sleep analysis. Deep learning methods demonstrate strong performance in sleep staging and respiratory event detection, especially using polysomnography data. However, limited external validation, heterogeneous datasets, and a lack of prospective clinical deployment remain major barriers to clinical translation.

Generative artificial intelligence (AI), including GANs, VAEs, and diffusion models, is increasingly used for synthesizing and enhancing medical images, helping address challenges such as limited data, expensive acquisition, and rare disease representation. This systematic review examines studies on generative AI methods for MRI, CT, X-ray, and pathology image synthesis from 2017 to 2026, focusing on synthesis tasks, evaluation strategies, and clinical utility. A PRISMA 2020-compliant search of PubMed, IEEE Xplore, Scopus, and Web of Science identified peer-reviewed research on generative models for medical image synthesis, augmentation, harmonization, or cross-modality translation. Findings show a shift from GAN-based methods to diffusion models post-2022, with MRI and CT studies emphasizing cross-modality translation, and X-ray and pathology studies focusing on augmentation and diagnostic utility. Despite GANs' continued dominance, diffusion models are gaining traction for improving image fidelity and diversity. However, evaluation practices remain inconsistent, with limited inclusion of clinically relevant assessments. This review follows PRISMA 2020 guidelines and provides a narrative synthesis of the evidence.

This systematic review examines the use of edge artificial intelligence (AI) and wearable sensors for real-time patient monitoring in smart hospitals and home settings, focusing on detecting deterioration, falls, arrhythmias, and infection-related changes. The review synthesizes studies from 2017 to 2026 on edge AI architectures, wearable sensor fusion, and clinical alert systems, emphasizing latency, power constraints, alert performance, and integration into clinical workflows. A PRISMA 2020-compliant search identified 127 studies from 2,100 records, with findings showing that while edge AI execution grew post-2020, it still represented a minority of designs. Sensor fusion was often linked to broader event coverage but increased implementation complexity. The review concludes that edge AI can reduce latency and enhance privacy but introduces challenges related to power usage, model complexity, device reliability, and maintenance, with limited clinical validation of alert systems and few studies addressing alert fatigue or clinician response.